CORCEPT THERAPEUTICS INC's ticker is CORT and the CUSIP is 218352102. A total of 191 filers reported holding CORCEPT THERAPEUTICS INC in Q4 2017. The put-call ratio across all filers is 1.03 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $29,142,641 | +51.3% | 1,069,651 | +23.6% | 0.02% | +66.7% |
| Q2 2023 | $19,256,463 | +26839.3% | 865,459 | -73.8% | 0.01% | -78.0% |
| Q1 2023 | $71,481 | +2187.4% | 3,300,152 | +2044.8% | 0.04% | +1950.0% |
| Q4 2022 | $3,125 | -99.9% | 153,870 | +80.5% | 0.00% | +100.0% |
| Q3 2022 | $2,186,000 | -86.6% | 85,252 | -87.6% | 0.00% | -90.0% |
| Q2 2022 | $16,320,000 | -61.7% | 686,309 | -63.7% | 0.01% | -54.5% |
| Q1 2022 | $42,613,000 | -53.3% | 1,892,241 | -59.0% | 0.02% | -53.2% |
| Q4 2021 | $91,340,000 | +3677.5% | 4,613,135 | +3655.3% | 0.05% | +4600.0% |
| Q3 2021 | $2,418,000 | +0.6% | 122,844 | +12.5% | 0.00% | 0.0% |
| Q2 2021 | $2,403,000 | +446.1% | 109,226 | +491.0% | 0.00% | – |
| Q1 2021 | $440,000 | -79.9% | 18,482 | -85.3% | 0.00% | -100.0% |
| Q3 2020 | $2,191,000 | -76.9% | 125,895 | -77.7% | 0.00% | -76.9% |
| Q2 2020 | $9,478,000 | +126.9% | 563,490 | +60.4% | 0.01% | +44.4% |
| Q1 2020 | $4,177,000 | -26.3% | 351,337 | -25.0% | 0.01% | +28.6% |
| Q4 2019 | $5,671,000 | -43.8% | 468,699 | -34.3% | 0.01% | -56.2% |
| Q3 2019 | $10,085,000 | +357.6% | 713,516 | +261.0% | 0.02% | +433.3% |
| Q2 2019 | $2,204,000 | -69.8% | 197,643 | -68.2% | 0.00% | -72.7% |
| Q1 2019 | $7,305,000 | -37.1% | 622,273 | -28.4% | 0.01% | -38.9% |
| Q4 2018 | $11,608,000 | +223.0% | 868,837 | +239.0% | 0.02% | +350.0% |
| Q3 2018 | $3,594,000 | +0.3% | 256,319 | +12.5% | 0.00% | -20.0% |
| Q2 2018 | $3,583,000 | -68.9% | 227,904 | -67.5% | 0.01% | -66.7% |
| Q1 2018 | $11,538,000 | -50.0% | 701,408 | -45.1% | 0.02% | -51.6% |
| Q4 2017 | $23,085,000 | +26.3% | 1,278,218 | +35.0% | 0.03% | +10.7% |
| Q3 2017 | $18,276,000 | +137.5% | 946,931 | +45.2% | 0.03% | +100.0% |
| Q2 2017 | $7,696,000 | +240.4% | 652,162 | +216.1% | 0.01% | +250.0% |
| Q1 2017 | $2,261,000 | +109.7% | 206,324 | +39.0% | 0.00% | +100.0% |
| Q4 2016 | $1,078,000 | -35.4% | 148,462 | -42.1% | 0.00% | -33.3% |
| Q3 2016 | $1,668,000 | +44.3% | 256,555 | +21.2% | 0.00% | 0.0% |
| Q2 2016 | $1,156,000 | +447.9% | 211,724 | +370.6% | 0.00% | +200.0% |
| Q1 2016 | $211,000 | -81.6% | 44,993 | -80.5% | 0.00% | -50.0% |
| Q4 2015 | $1,149,000 | -3.6% | 230,725 | -27.2% | 0.00% | 0.0% |
| Q3 2015 | $1,192,000 | +62.6% | 316,996 | +159.9% | 0.00% | +100.0% |
| Q2 2015 | $733,000 | +409.0% | 121,986 | +373.8% | 0.00% | – |
| Q1 2015 | $144,000 | -81.8% | 25,745 | -85.8% | 0.00% | -100.0% |
| Q1 2014 | $793,000 | – | 181,800 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| INGALLS & SNYDER LLC | 8,712,176 | $123,147,000 | 6.01% |
| TANAKA CAPITAL MANAGEMENT INC | 74,139 | $1,048,000 | 3.38% |
| S&T BANK/PA | 625,078 | $8,859,000 | 1.92% |
| Parallel Advisors, LLC | 1,277,851 | $18,062,000 | 1.55% |
| AJ WEALTH STRATEGIES, LLC | 595,828 | $8,422,000 | 1.11% |
| Matarin Capital Management, LLC | 891,636 | $12,603,000 | 0.95% |
| Capital Impact Advisors, LLC | 162,544 | $2,370,000 | 0.90% |
| AMI ASSET MANAGEMENT CORP | 775,685 | $10,964,000 | 0.57% |
| Birchview Capital, LP | 50,000 | $707,000 | 0.47% |
| Zebra Capital Management LLC | 25,409 | $359,000 | 0.39% |